Abstract: This work introduces an approach to compute the periodic phase diagram of micromagnetic systems by solving a periodic linearized Landau-Lifshitz–Gilbert (LLG) equation using an eigenvalue ...

View post: Walmart Has a CarPlay Adapter on Sale for $28 We pit the top Chevy Silverado 1500 trims head-to-head. The High Country emphasizes luxury, while the ZR2 focuses on off-road capability and ...

Medley Therapeutics (formerly YAP Therapeutics) has dosed the first cohort (n=3) with YAP101 in the Phase 1 SALVADOR-HF trial at The Texas Heart Institute at Baylor College of Medicine in the Baylor ...

Enrollment completed for heart failure with reduced ejection fraction cohort of RENEU-HF, Phase 2b study of JK07; topline results expected in 1H26 Company initiated RENEU-PH, Phase 2a study of JK07 in ...

Nikon has created a disturbance in the Force with the new ZR, its first compact cinema camera, plus it's developed in collaboration with RED Digital Cinema no less. The ZR promises the best that RED ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has reached the market that could further alter the HF landscape. The FDA has ...

Rotorcraft manufacturer Bell has advanced to the build stage of a secretive high-speed vertical-lift X-plane competition for the US military. The company revealed on 9 July it has been selected for ...

Lorundrostat, a novel aldosterone synthase inhibitor, lowered blood pressure among adults with uncontrolled hypertension in a phase 3 trial, including in treatment-resistant cases. Adverse events ...

It's the last moon in June, and there are plenty of geological features to see, even without a telescope, all thanks to the ever-changing lunar cycle. The lunar cycle is a series of eight unique ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Quasi-ternary dextran-water-polyethylene glycol (D-W-PEG) systems can undergo a ...

Patients who have cutaneous squamous-cell carcinoma with high-risk features are at risk for recurrence after definitive local therapy. The benefit of systemic adjuvant therapy options has not been ...